LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Bacterial Blood Infections Tied to Heightened Colon Cancer Risk

By LabMedica International staff writers
Posted on 12 May 2020
Print article
Image: Clostridium septicum is a gram positive, spore forming, obligate anaerobic bacterium and increases the risk of colon cancer (Photo courtesy of Alchetron).
Image: Clostridium septicum is a gram positive, spore forming, obligate anaerobic bacterium and increases the risk of colon cancer (Photo courtesy of Alchetron).
Colorectal cancer occurs in the colon or the rectum and it is the third most common type of cancer in the USA. Around 90% of cases occur in people aged 50 years or older. As well as age, risk factors include a family history of colorectal cancer, some genetic syndromes, obesity, and a lack of exercise, a diet low in fruit and vegetables, and inflammatory bowel disease.

Anaerobic bacteria, unlike aerobic bacteria, do not require oxygen in order to function. They are a normal part of the human body, existing in various locations, including the gut. They usually do not cause infections, but when they do, it is most often in the area that the bacteria inhabit. A new study indicates that there is an association between blood infections caused by certain types of bacteria and an increased risk of colon cancer.

A team of scientists associated with Odense University Hospital (Odense, Denmark) gathered data on 45,760 blood infections, including information about the type of pathogens present in the participants’ bloodstreams. Of the 45,760 people who had a bacterial blood infection, 492 (1.1%) later developed colorectal cancer. Of these, 241 (0.5%) were within the first year of the bacterial blood infection. The team matched each of these people by age and sex to a control group of five people who had not had a blood infection.

The investigators reported that compared to people with blood infections caused by aerobic bacteria such as Escherichia coli or Staphylococcus aureus or people without blood infections, those anaerobic bacteria associated with an increased risk of colorectal cancer were: Clostridium septicum (tied to a 42-times increased risk within a year after a blood infection, and a 21-times higher risk overall); and Bacteroides ovatus, (tied to a 13-times increased risk within a year after a blood infection, and a six times higher risk overall).

Ulrik Stenz Justesen, MD, a Clinical Microbiologist and senior author of the study, said, “At this stage we are not sure if the bacteria are directly causing cases of colorectal cancer, or if the blood infection with these bacteria is itself caused by the cancer. It's an example of the question 'is this the chicken or the egg? With regards to screening, if we saw these high risk bacteria in combination with advanced age, then it would definitely be worth screening the person for colorectal cancer.” The study was slated to be presented at the European Congress of Clinical Microbiology and Infectious Diseases which was to be held Apr 18 - 21, 2020 in Paris, France.

Related Links:
Odense University Hospital

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
TORCH Infections Test
TORCH Panel

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.